O câncer colorretal (CCR) é importante causa de morte no Brasil, representando a segunda causa de morbimortalidade por câncer nas regiões Sudeste e Sul. Foi uma das primeiras neoplasias malignas a ter modelo de carcinogênese identificado. Os objetivos deste trabalho foram avaliar a expressão do NF-KB e da survivina na progressão do CCR, sua relação com alvos moleculares envolvidos na sobrevivência celular [proibitina, fator de necrose tumoral (TNFR1), p53, B- catenina]; invasão (metaloproteinases 2 e 9 - MMP), angiogênese (fator de crescimento endotelial vascular VEGF) e apoptose (caspase 3 e método do Túnel). Trata-se de estudo retrospectivo baseado na análise histopatológica de dezoito casos de adenomas com displasia de alto (AG) e baixo grau (BG), respectivamente; dez casos de adenocarcinoma bem, moderado e pouco diferenciado, respectivamente, nove casos de lesões serrilhadas e nove biópsias colorretais (controle) selecionados aleatoriamente no Serviço de Patologia do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, no período de 2000 a 2009. Foram construídos arranjos de matriz tecidual para representar os casos de adenocarcinomas e cinco casos de adenomas >1 cm de diâmetro. A detecção do NF-KB foi realizada pelo método de Southwestern imunoistoquímica. Avaliou-se a expressão imunoistoquímica da survivina, proibitina, TNFR1, p53, B-catenina, MMPs 2 e 9, VEGF, caspase 3 e Túnel. Não observamos expressão imunoistoquímica do NF-KB em 70% dos casos de adenocarcinomas, em 72% dos adenomas AG e em 89% das lesões serrilhadas; a marcação foi positiva em 66% e 56% dos casos de adenoma do BG e controle, respectivamente. Expressões da survivina, proibitina citoplasmática, TNFR1, p53, MMP 2 e 9 foram crescentes na seqüência adenoma-carcinoma, sem aparente modulação pelo NF-KB. A survivina suprimiu ação da caspase 3, exceto nos adenomas BG e controle, com baixos níveis de apoptose ao túnel. Lesões serrilhadas e controle apresentaram baixa expressão do TNFR1 e da proibitina citoplasmática, ausência de marcação da p53 e MMPs 2 e 9, exceto um caso controle. Identificou-se marcação nuclear da proibitina nos adenocarcinomas pouco diferenciados, adenomas AG e BG. A expressão da p53 relacionou-se ao grau de displasia nos adenomas e à desregulação da survivina. Observou-se expressão citoplasmática e nuclear da B- catenina nos adenocarcinomas, adenomas AG e BG. As lesões serrilhadas exibiram expressão citoplasmática em 44% dos casos. O grupo controle exibiu expressão preservada da B-catenina. Identificou-se expressão do VEGF nos adenocarcinomas, relacionada à perda de diferenciação celular, presença de metástases, não correlacionada ao NF-KB. Com base nos nossos resultados, sugerimos a desregulação da B- catenina como possível responsável pela inibição do NF-KB; além de sua participação na desregulação da survivina juntamente com a p53. As lesões serrilhadas não exibiram indícios sugestivos de inibição do NF- KB pela B-catenina.A survivina, devido propriedades anti-apoptóticas, emerge como potencial alvo terapêutico no tratamento do CCR, confirmando estudos anteriores. / Colorectal cancer (CRC) is an important cause of death in Brazil, representing the second leading cause of cancer mortality in the Southeast and South. It was among the first malignancies that have the carcinogenesis model identified.The aim of this study was to evaluate the expression of NF-KB and survivin in the progression of CRC, its relationship with molecular targets involved in cell survival [prohibitin, tumor necrosis factor (TNFR1), p53,B-catenina], invasion (metalloproteinases 2 and 9 - MMP), angiogenesis (vascular endothelial growth factor VEGF) and apoptosis (caspase 3 and method Tunnel). This is a retrospective study based on the histopathological analyses of eighteen cases of high- (HG) and low- grade dysplastic (LG) adenomas, respectively; ten cases of adenocarcinoma well, moderately and poorly differentiated, respectively, nine cases of serrated lesions e nine biopsies (control); randomly selected in the Pathology Service of the University Hospital of the Faculty of Medicine of Ribeirão Preto, University of São Paulo from 2000 to 2009. Tissue microarray were constructed to represent the cases of adenocarcinomas and five cases of adenomas > 1cm in diameter. Detection of NF-KB was performed by the Southwestern immunohistochemistry method. We evaluated immunohistochemical expression of survivin, prohibitin, TNFR1, p53, B- catenin, MMPs 2 and 9, VEGF, caspase 3 and method Tunnel. We did not observe immunohistochemical expression of NF-KB in 70% of cases of adenocarcinomas, in 72% of HG adenomas and 89% of lesions serrated; staining was positive in 66% and 56% of cases of LG adenoma and control, respectively. Expressions of survivin, cytoplasmic prohibitin, TNFR1, p53, MMPs 2 and 9 were increasing in adenoma-carcinoma sequence, without apparent modulation by NF-KB. Survivin suppressed action of caspase 3, except in BG adenomas and control, with low levels of apoptosis to the tunnel. Serrated lesions and control showed low expression of TNFR1 and cytoplasmic prohibitin, the absence of staining of p53 and MMPs2 and 9, except for one control. We identified nuclear staining of prohibitin in poorly differentiated adenocarcinomas, HG and LG adenomas. Expression of p53 was related to the grade of dysplasia in adenomas and deregulation of survivin.The expression of the cytoplasmic and nuclear B-catenin was observed in adenocarcinoma, HG and LG adenoma. Serrated lesions exhibited cytoplasmic expression in 44% of cases. Control group exhibited preserved expression of B-catenin. It was identified VEGF expression in adenocarcinomas, related to the loss of cellular differentiation, metastasis, not correlated with NF-KB. According to our results, we suggest that deregulation of catenin is possible responsible for the inhibition of NF-KB besides their participation in the deregulation of survivin with p53.Serrated lesions exhibited no evidence suggestive of inhibition of NF-KB by B-catenin. Survivin emerges as a potential therapeutic target in the treatment of CRC due to their anti-apoptotic properties, confirming previous studies.

Thesis (M.Sc. (Biochemistry)) -- University of Limpopo, 2019 / Survivin is the smallest and a well-studied member of the inhibitors of apoptosis proteins (IAPs) family, which is involved in the regulation of cell division, inhibition of both caspasedependent and -independent apoptosis in cancer cells and promotion of angiogenesis. Survivin is detectable during embryonic and foetal development but is undetectable in normal adult tissues. It is, however, expressed in transformed cell lines as well as in most common types of human cancers. Regulation of survivin remains poorly understood, and the discovery of the regulatory biomolecules, microRNAs (MiRs) present an interesting opportunity to investigate the regulation of this protein and its variants in cancers, especially breast cancer. Additionally, the expression of the survivin splice variants during cell cycle progression and apoptosis is not fully understood. The aims of this study were to investigate the role of arsenic trioxide on the expression of survivin splice variants and their specific microRNAs during cell cycle progression and apoptosis in human breast cancer MCF-7 cells. The study also aimed at ascertaining the toxicity and efficacy of using coal fly ash-derived β-cyclodextrin carbon nanospheres to deliver arsenic trioxide into the MCF-7 cells. Carbon nanospheres (CNSs) were synthesised using a chemical vapour deposition method while arsenic trioxide was deposited using wet impregnation method to form the arsenic trioxide-β-cyclodextrin carbon nanospheres (ATO-β-cyclodextrin-CNSs). The formation of the CNSs and the loading of arsenic trioxide to CNSs were confirmed using scanning electron microscopy/energy dispersive X-ray detection (SEM-EDX). The in vitro cytotoxicity effect of the β-cyclodextrin carbon nanospheres (CNSs), arsenic trioxide and arsenic trioxide-β-cyclodextrin CNSs against KMST-6 and MCF-7 cells was analysed using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) Assay, Muse® Count and Viability Assay and light/fluorescence microscopy. Cellular apoptosis, cell cycle analysis, Multi-Caspase activation, mitochondrial membrane potential, MAPK activation and PI3K activation were analysed using the Muse® Cell Analyser. Polymerase Chain Reaction (PCR) and Immunohistochemistry were used to analyse survivin mRNA variants and protein expression, respectively. The survivin specific MiRs were predicted using both bioinformatics platforms and literature surveys. In order to understand the applicability of delivering arsenic trioxide for the treatment of breast cancer, skin fibroblast (KMST-6) and MCF-7 cells were exposed to β-cyclodextrin CNSs. The novel β-cyclodextrin CNSs did not show any cytotoxic effect on the KMST-6 cells but demonstrated such activity against the MCF-7 cells. More so, arsenic trioxide-βcyclodextrin CNSs were found to significantly reduce the viability of the MCF-7 cells and were shown to inhibit their cell growth through the induction of apoptosis. The MTT Assay results revealed arsenic trioxide inhibited the growth of the MCF-7 cells in a concentration-dependent manner. The Muse® Cell Analyser showed that arsenic trioxide induced G2/M cell cycle arrest and promoted cellular apoptosis without any damage to the mitochondrial membrane of MCF-7 cells. Furthermore, arsenic trioxide also deactivated two survival pathways, Mitogen-Activated Protein Kinase (MAPK) and Phosphoinositide 3-Kinase (PI3K) signalling pathways in MCF-7 cells. The deactivation of the two pathways was shown to be accompanied by the upregulation of survivin 3α during arsenic trioxide-induced G2/M cell cycle arrest and apoptosis. Survivin 2B was found to be upregulated only during arsenic trioxide-induced G2/M cell cycle arrest, but downregulated during arsenic trioxide-induced apoptosis. However, wild-type survivin was highly expressed in untreated MCF-7 cells, but the expression was upregulated during arsenic trioxide-induced G2/M cell cycle arrest and was downregulated during arsenic trioxide-induced apoptosis. Survivin variant ΔEx3 was undetected in both untreated and treated MCF-7 cells. Survivin 2α was upregulated during arsenic trioxideinduced apoptosis whereas, survivin 3B was only detected in the untreated MCF-7 cells. Additionally, survivin proteins were localised in both the nuclei and cytoplasm in MCF-7 cells and highly upregulated during arsenic trioxide-induced G2/M cell cycle arrest, which can be attributed to the upregulation of survivin-2B. Using TargetScan, MIRD and mirTarbase, a few MiRs were identified and confirmed to target wild-type survivin, survivin 2B and survivin ΔEx3. These include the MiR-542-3p and MiR-335-5p, which are both upregulated during apoptosis and MiR-218-5p, which is upregulated during cell arrest. MiR-218-5p targets survivin 2B, which was upregulated during G2M cell cycle arrest. The fly ash-derived CNSs can be used to deliver arsenic trioxide for therapeutic purposes, especially against breast cancer. Most importantly, these nanoparticles induced typical apoptotic characteristics in breast cancer MCF-7 cells. Arsenic trioxide can be used as therapeutic target for breast cancer treatment and nanotechnology can be used for its delivery. This study provided the first evidence that novel survivin 2B splice variant may be involved in the regulation of arsenic trioxide-induced G2/M cell cycle arrest only. This splice variant can therefore, be targeted for therapeutic purposes against Luminal A breast cancer cells

O propósito do presente estudo foi analisar as células epiteliais odontogênicas procurando um entendimento maior sobre a natureza e conseqüentemente o comportamento de algumas lesões odontogênicas. A expressão imunoistoquímica de p53 e PCNA foi analisada em cisto radicular, cisto dentígero, ceratocisto odontogênico e cisto odontogênico calcificante (Cisto de Gorlin) onde verificou-se que no cisto radicular e cisto dentígero a expressão dos marcadores está relacionado com proliferação e stress celular causado pelo estímulo inflamatório e em ceratocisto odontogênico e Cisto de Gorlin a expressão dos marcadores corresponde a proliferação celular não descartando também a presença de mutação no gene TP53. Também foi observada a expressão de Ki-67, EGFR e Survivin em folículo pericoronário, ceratocisto odontogênico e cisto dentígero que mostrou que as células epiteliais dos folículos pericoronários têm potencial proliferativo para formar lesões odontogênicas e que a proliferação das células do cisto dentígero é relacionada com o estímulo inflamatório. Todos os marcadores estudados comprovaram a natureza neoplásica do ceratocisto odontogênico. / The purpose of this study was to analyze odontogenic epithelial cells to contribute to the knowledge about their nature and, consequently, about the behavior of certain odontogenic lesions. Immunohistochemical expressions of p53 and PCNA were analyzed in radicular cysts, dentigerous cysts, odontogenic keratocysts and calcifying odontogenic cysts (Gorlin cyst). In radicular and dentigerous cysts, the expression of these markers was associated with cell proliferation and stress caused by an inflammatory stimulus. In keratocysts and Gorlin cysts, the expression of markers corresponded to cell proliferation. Results also showed possible mutation in TP53 gene. Also, Ki-67, EGFR and Survivin were expressed in pericoronal follicles, odontogenic keratocysts and dentigerous cysts, which demonstrated that epithelial cells of pericoronal follicles may proliferate to form odontogenic lesions and that cell proliferation in dentigerous cysts was associated with an inflammatory stimulus. The analysis of all markers under study confirmed the neoplastic nature of odontogenic keratocysts.

O propósito do presente estudo foi analisar as células epiteliais odontogênicas procurando um entendimento maior sobre a natureza e conseqüentemente o comportamento de algumas lesões odontogênicas. A expressão imunoistoquímica de p53 e PCNA foi analisada em cisto radicular, cisto dentígero, ceratocisto odontogênico e cisto odontogênico calcificante (Cisto de Gorlin) onde verificou-se que no cisto radicular e cisto dentígero a expressão dos marcadores está relacionado com proliferação e stress celular causado pelo estímulo inflamatório e em ceratocisto odontogênico e Cisto de Gorlin a expressão dos marcadores corresponde a proliferação celular não descartando também a presença de mutação no gene TP53. Também foi observada a expressão de Ki-67, EGFR e Survivin em folículo pericoronário, ceratocisto odontogênico e cisto dentígero que mostrou que as células epiteliais dos folículos pericoronários têm potencial proliferativo para formar lesões odontogênicas e que a proliferação das células do cisto dentígero é relacionada com o estímulo inflamatório. Todos os marcadores estudados comprovaram a natureza neoplásica do ceratocisto odontogênico. / The purpose of this study was to analyze odontogenic epithelial cells to contribute to the knowledge about their nature and, consequently, about the behavior of certain odontogenic lesions. Immunohistochemical expressions of p53 and PCNA were analyzed in radicular cysts, dentigerous cysts, odontogenic keratocysts and calcifying odontogenic cysts (Gorlin cyst). In radicular and dentigerous cysts, the expression of these markers was associated with cell proliferation and stress caused by an inflammatory stimulus. In keratocysts and Gorlin cysts, the expression of markers corresponded to cell proliferation. Results also showed possible mutation in TP53 gene. Also, Ki-67, EGFR and Survivin were expressed in pericoronal follicles, odontogenic keratocysts and dentigerous cysts, which demonstrated that epithelial cells of pericoronal follicles may proliferate to form odontogenic lesions and that cell proliferation in dentigerous cysts was associated with an inflammatory stimulus. The analysis of all markers under study confirmed the neoplastic nature of odontogenic keratocysts.

SKIP and BIR/Survivin are evolutionarily conserved proteins. SKIP is a known transcription and splicing cofactor while BIR-1/Survivin regulates cell division, gene expression and development. Loss of function of C. elegans SKIP (SKP-1) and BIR-1 induces overlapping developmental phenotypes. In order to uncover the possible interactions of SKP-1 and BIR-1 on the protein level, we screened the complete C. elegans mRNA library using the yeast two-hybrid system. These experiments identified partially overlapping categories of proteins as SKP-1 and BIR-1 interactors. The interacting proteins included ribosomal proteins, transcription factors, translation factors and cytoskeletal and motor proteins suggesting involvement of the two studied proteins in multiple protein complexes. To visualize the effect of BIR-1 on the proteome of C. elegans we induced a short time pulse BIR-1 overexpression in synchronized L1 larvae. This led to a dramatic alteration of the whole proteome pattern indicating that BIR-1 alone has the capacity to alter the chromatographic profile of many target proteins including proteins found to be interactors in yeast two hybrid screens. The results were validated for ribosomal proteins RPS-3, RPL-5, non-muscle myosin and TAC-1, a transcription cofactor and a centrosome associated...

O propósito do presente estudo foi analisar as células epiteliais odontogênicas procurando um entendimento maior sobre a natureza e conseqüentemente o comportamento de algumas lesões odontogênicas. A expressão imunoistoquímica de p53 e PCNA foi analisada em cisto radicular, cisto dentígero, ceratocisto odontogênico e cisto odontogênico calcificante (Cisto de Gorlin) onde verificou-se que no cisto radicular e cisto dentígero a expressão dos marcadores está relacionado com proliferação e stress celular causado pelo estímulo inflamatório e em ceratocisto odontogênico e Cisto de Gorlin a expressão dos marcadores corresponde a proliferação celular não descartando também a presença de mutação no gene TP53. Também foi observada a expressão de Ki-67, EGFR e Survivin em folículo pericoronário, ceratocisto odontogênico e cisto dentígero que mostrou que as células epiteliais dos folículos pericoronários têm potencial proliferativo para formar lesões odontogênicas e que a proliferação das células do cisto dentígero é relacionada com o estímulo inflamatório. Todos os marcadores estudados comprovaram a natureza neoplásica do ceratocisto odontogênico. / The purpose of this study was to analyze odontogenic epithelial cells to contribute to the knowledge about their nature and, consequently, about the behavior of certain odontogenic lesions. Immunohistochemical expressions of p53 and PCNA were analyzed in radicular cysts, dentigerous cysts, odontogenic keratocysts and calcifying odontogenic cysts (Gorlin cyst). In radicular and dentigerous cysts, the expression of these markers was associated with cell proliferation and stress caused by an inflammatory stimulus. In keratocysts and Gorlin cysts, the expression of markers corresponded to cell proliferation. Results also showed possible mutation in TP53 gene. Also, Ki-67, EGFR and Survivin were expressed in pericoronal follicles, odontogenic keratocysts and dentigerous cysts, which demonstrated that epithelial cells of pericoronal follicles may proliferate to form odontogenic lesions and that cell proliferation in dentigerous cysts was associated with an inflammatory stimulus. The analysis of all markers under study confirmed the neoplastic nature of odontogenic keratocysts.

O Glioblastoma é um dos tumores mais agressivos do sistema nervoso central e entre as diversas neoplasias possui um dos piores prognósticos. Mesmo com as novas estratégias de tratamento, a sobrevida de pacientes portadores de glioblastoma continua sendo muito baixa, sendo a temozolomida (TMZ) o agente mais comum usado no seu tratamento. O ácido tetra-o-metil nordihidroguaiarético (M4N), é um novo agente terapêutico que funciona como um repressor transcricional global de genes dependentes do fator de transcrição Sp1, tais como Survivina e Cdk1. No presente estudo, foram investigados os níveis de expressão do gene Survivina, suas variantes gênicas por splicing alternativo e Cdk1 em amostras tumorais e linhagens celulares de GBM. Adicionalmente, foram investigados os efeitos do M4N em combinação ou não com TMZ e/ou radiação em culturas primárias e linhagens celulares de GBM. Ensaios de qRT-PCR foram realizados para determiner a expressão de mRNA das variantes gênicas de Survivina e Cdk1. A proliferação celular foi analisada pelo ensaio XTT e os niveis de apoptose e variações do ciclo celular foram determinados por citometría de fluxo. Analises de combinação de drogas utilizando diferentes estratégias de administração (simultânea e seqüencial) foram realizados baseados no método de Chou-Talalay em linhagens celulares e culturas primárias de GBM. Para os ensaios de sobrevivência clonogênica, foram utilizadas as doses de 2, 4 e 6 Gy de radiação gamma. Todas as variantes por splicing alternativo de Survivina e o gene Cdk1 foram expressos em amostras (n=16) e linhagens celulares (n=6) de GBM, exceto a variante Survivina-2B que apenas foi expressa nas linhagens celulares de GBM. O tratamento com M4N diminuiu a expressão de Cdk1, Survivina e a variante Survivina-Ex3, enquanto que houve um aumento da expressão da variante Survivina-2B. O M4N diminuiu a proliferação celular de forma isolada e sinérgicamente quando combinada com TMZ. Além disso, o M4N aumentou os efeitos da radiação, principalmente quando associado com TMZ. O M4N causou morte celular apoptótica, diminuição do índice mitótico e parada do ciclo celular principalmente na fase x G2/M. Os resultados do presente estudo sugerem a potencial aplicação clínica de M4N em combinação com TMZ e radiação no tratamento do GBM. / Glioblastoma (GBM), one of the most human malignant neoplasia, responds poorly to current treatment modalities, being temozolomide (TMZ) the most used drug in its treatment. TetraO-methyl Nordihydroguaiaretic Acid (M4N) is a global transcriptional repressor of genes dependents of Sp1 transcription factor, such as Survivin and Cdk1. In this study was evaluated the gene expression of Survivin, their spliced-variants and Cdk1 in GBM samples and cell lines. Moreover, it was investigated the effects of M4N combined or not with TMZ and/or radiation on primary cultures and cell lines of GBM. qRT-PCR assays were performed to determine the Survivin-spliced variants and Cdk1 gene mRNA expression in GBM tumor samples and cell lines. Cell proliferation was measured by XTT assay and cell cycle and apoptosis were determined by flow cytometry. Drug combination analyzes using different schedules of administration (simultaneous and sequential) were performed based in ChouTalalay method on GBM cell lines and primary cultures. For clonogenic survival, it was used the doses of 2, 4, and 6 Gy of gamma radiation. All Survivin-spliced variants and Cdk1 gene were expressed in GBM samples (n=16) and cell lines (n=6), except the Survivin-2B variant that was only expressed in GBM cell lines. M4N treatment down regulated the expression of Cdk1, Survivin and Survivin-Ex3 variant, while the Survivin-2B variant was up-regulated. M4N decreased the cell proliferation separately and synergistically with TMZ, moreover it enhanced the radiation effects, mainly when associated with TMZ. M4N also induced apoptotic cell death, decreased mitotic index and arrested the cell cycle mainly in G2/M phase. Our results suggest a potential clinical application of M4N in combination with TMZ and radiation in GB treatment.

SKIP and BIR/Survivin are evolutionarily conserved proteins. SKIP is a known transcription and splicing cofactor while BIR-1/Survivin regulates cell division, gene expression and development. Loss of function of C. elegans SKIP (SKP-1) and BIR-1 induces overlapping developmental phenotypes. In order to uncover the possible interactions of SKP-1 and BIR-1 on the protein level, we screened the complete C. elegans mRNA library using the yeast two-hybrid system. These experiments identified partially overlapping categories of proteins as SKP-1 and BIR-1 interactors. The interacting proteins included ribosomal proteins, transcription factors, translation factors and cytoskeletal and motor proteins suggesting involvement of the two studied proteins in multiple protein complexes. To visualize the effect of BIR-1 on the proteome of C. elegans we induced a short time pulse BIR-1 overexpression in synchronized L1 larvae. This led to a dramatic alteration of the whole proteome pattern indicating that BIR-1 alone has the capacity to alter the chromatographic profile of many target proteins including proteins found to be interactors in yeast two hybrid screens. The results were validated for ribosomal proteins RPS-3, RPL-5, non-muscle myosin and TAC-1, a transcription cofactor and a centrosome associated...

Indiana University-Purdue University Indianapolis (IUPUI) / The anti-apoptotic protein Survivin and the cyclin-dependent kinase p34Cdc2 are involved in cell cycle progression and apoptosis. Activation of Cdc2 is required for its pro-apoptotic activity, which can be inhibited by phosphorylation at Tyrosine-15 (Tyr15). In transduced IL-3-dependent murine BaF3 hematopoietic cells, over-expression of wild-type-(wt)-Survivin increased Cdc2-Tyr15 phosphorylation, while over-expression of a dominant-negative-(dn)-T34A-Survivin construct decreased its phosphorylation. The increased phospho-Tyr15 levels associated with ectopic Survivin directly correlated with enhanced BaF3 cell survival in the absence of growth factors, and low phospho-Tyr15 levels observed in cells expressing ectopic dn-Survivin correlated with decreased survival. BaF3 cells transduced with Internal Tandem Duplication (ITD) mutations of the Flt3 receptor that results in increased Survivin levels, also contained increased levels of Tyr15 phosphorylated Cdc2. In BaF3 cells over-expressing wt-Survivin, 2-fold higher levels of Wee1 protein were observed compared to cells expressing control vector alone. Treatment of control BaF3 cells with the caspase-3 inhibitor Ac-DEVD-CHO increased both Cdc2-Tyr15 phosphorylation and Wee1 protein levels. In a similar fashion over-expression of wt-Survivin in these cells maintained high levels of Tyr15 phosphorylated Cdc2 and Wee1 protein. In MCF7 human breast cancer cells that lack caspase-3, increase of Tyr15 phosphorylated Cdc2 and Wee1 kinase protein by caspase-3, -7 or a pan-caspase inhibitor was absent, linking Survivin and caspase-3 to the increase of Wee1 and Tyr15 phosphorylation of Cdc2. To further link Survivin and Cdc2, we treated cells with AICAR and 17-AAG that inhibit Hsp90, which is known to be required for Survivin stability. Treatment of BaF3 cells expressing wt-Survivin with AICAR and 17-AAG decreased Cdc2-Tyr15 phosphorylation compared to vehicle-treated control cells. Taken together, these results indicate that Survivin protects the Cdc2-Tyr15-targeting kinase Wee1 from degradation by caspase-3 which leads to increased inhibitory Cdc2-Tyr15 phosphorylation resulting in reduced apoptosis and enhanced survival.

No description available.